This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked MRPL47 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-MRPL47 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~29.5 kDa | |
| Observed band | 72 kDa | |
| Gel | 12–15% (standard starting point) | |
| Positive control | Appendix (IHC candidate; verify WB) +4 more | |
| Negative control | Ovary (IHC candidate; verify WB) |
| PTM | Acetylated | |
| Caveat | Peptide-blocking control | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 3 isoform(s) |
The A14516 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | the lysates from 293 cells (catalog A14516) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | A14516; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
MRPL47 is predicted at 29.5 kDa, while antibody QC reports 72 kDa; the cause of this difference is not established.
| Band at 72 kDa | empirical MRPL47 antibody band; its identity and migration cause require confirmation |
| Band near 29.5 kDa | consistent with the predicted protein mass, but identity requires confirmation |
| Several bands at different positions | isoforms 1, 2, and 3 are annotated, but distinct migration is unproven |
| Band below the full-length position | possible mitochondrial transit-peptide processing; cleavage extent is unspecified |
| Predicted mass | 29.5 kDa by sequence; the reported antibody band is 72 kDa |
| Isoforms 1, 2, and 3 | could differ in size, but their masses and migration are unspecified |
| N6-acetyllysine at residue 144 | is annotated without evidence of a visible size shift |
| Mitochondrial transit peptide | could yield a smaller processed form, but no cleavage site or mature mass is supplied |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | MRPL47 is mitochondrial and may be weak in total lysate | check mitochondrial enrichment and antibody performance |
| Band higher than expected | the reported 72 kDa band exceeds the 29.5 kDa prediction for an unknown reason | compare peptide-blocked and unblocked lanes and confirm with another antibody |
| Band lower than expected | transit-peptide processing or an isoform is possible, but neither migration is established | verify identity with an independent antibody and mitochondrial enrichment |
| Multiple bands | three isoforms are annotated, but their band positions are unknown | use peptide blocking and an independent antibody to identify specific bands |
| Weak or no signal | the mitochondrial target may be underrepresented in the sample | enrich mitochondria and verify sample loading |
| Fragments below expected size | protein degradation or processing may produce smaller species | compare fresh, protected samples and confirm bands with an independent antibody |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Appendix | glandular cells | High | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | High | Protein (IHC) | HPA → |
| Cerebellum | Purkinje cells | High | Protein (IHC) | HPA → |
| Colon | glandular cells | High | Protein (IHC) | HPA → |
| Duodenum | glandular cells | High | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Ovary | ovarian stroma cells | Not detected | Protein (IHC) | HPA → |
| Adipose tissue | adipocytes | Low | Protein (IHC) | HPA → |
| Heart muscle | cardiomyocytes | Low | Protein (IHC) | HPA → |
| Hippocampus | neuronal cells | Low | Protein (IHC) | HPA → |
| Lymph node | germinal center cells | Low | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for MRPL47, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-MRPL47 antibody, A14516, with reported human, mouse, and rat reactivity. Its Western blot image is described as using 293 cell lysate; the supplied evidence does not establish Western blot performance across all listed species.
Which to pick: A14516 is the only listed option and has a Western blot image from 293 cell lysate. For other sample types, the supplied record provides no sample-specific Western blot evidence.